Quick Answer
Olema Pharmaceuticals, Inc. reported Shares Outstanding of 81.38 million shares for fiscal year 2025.
Olema Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 81.38M | +9.5% |
| 2024 | 74.31M | +35.1% |
| 2023 | 54.99M | +36.5% |
| 2022 | 40.29M | +1.2% |
| 2021 | 39.80M | +1.2% |
| 2020 | 39.31M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 68.65M | +19.8% | +0.0% |
| June 30, 2025 | 68.63M | +19.9% | +0.4% |
| March 31, 2025 | 68.33M | +22.3% | -8.0% |
| December 31, 2024 | 74.31M | +35.1% | +29.7% |
| September 30, 2024 | 57.29M | +4.9% | +0.1% |
| June 30, 2024 | 57.25M | +39.2% | +2.5% |
| March 31, 2024 | 55.87M | +38.2% | +1.6% |
| December 31, 2023 | 54.99M | +36.5% | +0.7% |
- Olema Pharmaceuticals, Inc. showed an increase of +9.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Olema Pharmaceuticals, Inc.’s shares outstanding has grown by 107.0% (from 39.31 million shares to 81.38 million shares).
- The most recent figure is from Olema Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: